Product image of Lenzetto (Estradiol) supplied by GNH India

Lenzetto

Active Ingredient:
Estradiol
Origin:
EU

Lenzetto (Estradiol)

Estradiol, the active ingredient in Lenzetto, is a estrogen presented as a 0.025 mg/24h transdermal patch for transdermal use. It treats moderate to severe vasomotor symptoms of menopause, helps prevent osteoporosis in postmenopausal women, and addresses estrogen deficiency due to hypogonadism.

GNH India supplies Lenzetto as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lenzetto (estradiol) is used in hormone replacement therapy to manage estrogen‑dependent conditions.

  • Menopausal vasomotor symptoms: relief of moderate to severe hot flashes and night sweats.
  • Postmenopausal osteoporosis: prevention of bone loss and reduction of fracture risk.
  • Hypogonadism‑related estrogen deficiency: restoration of estrogen levels in women with hypogonadism.

How It Works

  • Estradiol in Lenzetto binds to intracellular estrogen receptors (ERα and ERβ), acting as an agonist that triggers conformational changes and promotes recruitment of co‑activators. This leads to transcriptional activation of estrogen‑responsive genes, resulting in the restoration of estrogenic effects on target tissues such as the hypothalamus, bone, and the cardiovascular system.

Side Effects

Adverse reactions to Lenzetto may vary in frequency and severity.

Common Side Effects

  • Skin irritation at application site: redness, itching or rash.
  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal discomfort.
  • Breast tenderness: mild swelling or soreness.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
  • Stroke or myocardial infarction: increased risk of cardiovascular events.
  • Endometrial hyperplasia or carcinoma: abnormal uterine bleeding.

Precautions & Warnings

Before prescribing Lenzetto, clinicians should consider several precautionary measures.

  • Assess cardiovascular risk: evaluate history of thromboembolic disease or stroke.
  • Review personal or family history of hormone‑sensitive cancers: breast, endometrial, ovarian.
  • Monitor liver function: estradiol is metabolized hepatically.
  • Evaluate lipid profile: estrogen therapy may affect cholesterol levels.
  • Counsel on smoking status: smoking increases thrombotic risk.
  • Store at room temperature: keep patch in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Lenzetto can interact with other medications, altering its efficacy or safety.

Major Interactions (Avoid)

  • Combined oral contraceptives or hormone therapy: increased risk of thromboembolism.
  • Anticoagulants (warfarin, direct oral anticoagulants): enhanced anticoagulant effect, monitor INR.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine): reduced estradiol plasma levels.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: possible alteration of blood pressure control.
  • Antidiabetic agents: estrogen may affect glucose metabolism.
  • SSRIs and SNRIs: may increase risk of hyponatremia.

Frequently Asked Questions

Lenzetto is a transdermal estradiol patch indicated for hormone replacement therapy. It is prescribed to relieve moderate to severe vasomotor symptoms of menopause, to prevent osteoporosis in postmenopausal women, and to treat estrogen deficiency caused by hypogonadism.

Estradiol in Lenzetto binds to estrogen receptors in target cells, acting as an agonist. This activates gene transcription pathways that restore estrogen‑dependent physiological functions, such as regulation of body temperature, bone remodeling, and maintenance of lipid metabolism.

The prescribed dose of Lenzetto is determined by the treating physician based on the patient’s clinical needs. The product is available as a 0.025 mg/24 hour transdermal patch, and the prescriber decides the frequency and duration of patch application.

Safety of Lenzetto in pregnancy and lactation has not been established. Because estradiol can affect fetal development, it is generally contraindicated in pregnant women, and caution is advised for nursing mothers. Consultation with a healthcare professional is essential.

To order Lenzetto, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and required import documentation.

Lenzetto delivers estradiol transdermally, providing more stable plasma levels and avoiding first‑pass hepatic metabolism compared with oral estradiol tablets. This route can reduce gastrointestinal side effects and may have a lower impact on liver‑produced clotting factors, though individual response varies.

Lenzetto patches should be stored at room temperature, below 25 °C, in their original packaging. Keep them away from moisture, direct sunlight and heat sources to maintain product integrity until the expiry date.

The patch is applied to clean, dry, hair‑free skin on the lower abdomen, buttock or upper arm. Press firmly for several seconds, then rotate the application site with each new patch to minimize skin irritation. Follow the prescriber’s schedule for patch replacement.

Serious risks include venous thromboembolism, stroke, myocardial infarction, and endometrial hyperplasia or carcinoma. Patients with a history of clotting disorders, cardiovascular disease, or hormone‑sensitive cancers should be monitored closely or may be contraindicated.

Lenzetto is contraindicated in women with known or suspected estrogen‑dependent malignancies, active or past thromboembolic disease, uncontrolled hypertension, liver disease, or those who are pregnant. It should also be used with caution in smokers and individuals with a history of cardiovascular events.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Estradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT